Global Tuberculosis Testing and Diagnostics Market Growth (Status and Outlook) 2025-2031

According to this study, the global Tuberculosis Testing and Diagnostics market size will reach US$ million by 2031.

Tuberculosis Testing and Diagnostics involve a range of medical procedures and tests used to detect and diagnose tuberculosis (TB) infections in individuals. These methods include the tuberculin skin test (TST), also known as the Mantoux test, and various blood tests that measure the immune response to TB-specific antigens. Advanced techniques like molecular tests (such as PCR) and chest X-rays can provide more accurate diagnoses, aiding in the detection of active TB infections or latent TB. Accurate TB diagnostics are crucial for timely treatment and controlling the spread of the disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Tuberculosis Testing and Diagnostics Industry Forecast” looks at past sales and reviews total world Tuberculosis Testing and Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Testing and Diagnostics sales for 2025 through 2031. With Tuberculosis Testing and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Testing and Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis Testing and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis Testing and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Testing and Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Testing and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Testing and Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Testing and Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Segmentation by Application:
Hospitals and Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver. Show more